Research News and Research

RSS

Getting ready for an outbreak of West Nile virus

Between now and then the Marion County Health Department will use a time-proven, research based, proactive approach to reducing the local mosquito population and limiting potential human cases of West Nile virus.

24 Apr 2004

Protein may help prevent autoimmune conditions like diabetes, lupus, arthritis and multiple sclerosis

A possibly important ally of the immune system that can help with the tricky task of separating friend from foe has been identified by scientists at Washington University School of Medicine in St. Louis.

23 Apr 2004

Scientists have developed a better form of omega-3 fish oil

University of Georgia scientists have developed a form of omega-3 fish oil that's easier for people to absorb and leaves no fishy aftertaste.

23 Apr 2004

7,000 U.S. hospital patients die each year and more than 750,000 are injured as a result of avoidable medication mistakes

Some 7,000 U.S. hospital patients die each year and more than 750,000 are injured as a result of medication mistakes. These errors have many causes, and many potential solutions, according to a Rutgers-Camden nursing scholar who has studied the topic extensively.

23 Apr 2004

Helping doctors to prescribe the right medication

With so many new drugs on the market to treat arthritis and related disorders, how do doctors know which ones to use?

23 Apr 2004

Canadian doctors oblivious to costs of prescribed drugs

For the most part, family physicians in British Columbia aren't even close when they guess the costs of the treatments and tests they prescribe for their patients, according to a new study published in the journal Canadian Family Physician.

23 Apr 2004

Respiratory syncytial virus, a common cold virus, can act as a 'hit and hide' virus

An international team of researchers has discovered that respiratory syncytial virus (RSV), a common cold virus causing bronchiolitis in children, can act as a 'hit and hide' virus. It was thought that the virus could only survive in the body for a few days, but these new results show that the virus can survive for many months or years, perhaps causing long-term effects on health, such as damage to the lungs.

23 Apr 2004

Dance Marathon to commit $10 million for new pediatric cancer pavilion

The 2004 Overall Committee for the Penn State IFC/Panhellenic Dance Marathon (THON) has announced that THON will commit $10 million over the next six years to create a pediatric cancer pavilion at Children's Hospital at Penn State Milton S. Hershey Medical Center.

23 Apr 2004

CellCept linked to reduced cancer incidence

A study presented today at an international transplant meeting showed that heart transplant patients treated with the immunosuppressant CellCeptÒ (mycophenolate mofetil) in standard immunosuppressive regimens had a significantly lower risk of developing cancer compared to those receiving non-CellCept-based treatment regimens.

23 Apr 2004

The April 2004 issue of Otolaryngology focuses on head and neck surgery

The efficacy of a new cancer-fighting virus is tested in the study, “Treatment of Solid Sarcomas in Immunocompetent Mice with Novel Oncolytic Herpes Simplex Viruses.” A team of multi-disciplinary Japanese researchers found that a weakened version of herpes simplex virus (HSV) effectively eradicated neck and flank tumors in mice.

23 Apr 2004

Certain cells from a mother can cause immunity illness in children

Certain cells from a mother persist in their children’s bodies and can provoke an immune response in which the child’s body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).

23 Apr 2004

Japanese scientists have created a viable mouse derived from two genetic mothers with no contribution by a male animal

Japanese scientists have created a viable mouse derived from two genetic mothers with no contribution by a male animal.

23 Apr 2004

Schools failing to support teens who are pregnant or new mothers

But another group of girls, also guaranteed educational equality through Title IX, have seen little benefit, says Wanda Pillow, a professor of educational policy at the University of Illinois at Urbana-Champaign.

23 Apr 2004

Idebenone continues to show promise in treating Friedreich’s ataxia (FA)

Idebenone, a compound similar to coenzyme Q10, continues to show promise in treating the heart complications of Friedreich's ataxia (FA), notes correspondence published in the Feb. 10 issue of Neurology.

23 Apr 2004

Palliative care improvements needed in Australia

While Australian expertise in palliative care to ease the suffering of dying people has developed rapidly over the past 20 years, there is still a long way to go, writes Professor Margaret O'Connor, who holds the inaugural Vivian Bullwinkel chair in palliative care nursing at Monash.

23 Apr 2004

Researchers make millions upon millions of drug-like peptides quickly and efficiently

Two Johns Hopkins scientists have figured out a simple way to make millions upon millions of drug-like peptides quickly and efficiently, overcoming a major hurdle to creating and screening huge "libraries" of these super-short proteins for use in drug development.

23 Apr 2004

Nitric oxide, a chemical messenger involved in bodily functions shuts down a protein involved in Parkinson's disease

Johns Hopkins researchers have discovered that nitric oxide, a chemical messenger involved in bodily functions from erection to nerves' communication, also shuts down a protein involved in Parkinson's disease.

23 Apr 2004

GSK and WHO collaborate to fight malaria

GlaxoSmithKline (GSK), the World Health Organisation's Special Programme for Research and Training in Tropical Diseases (WHO-TDR) and the Medicines for Malaria Venture (MMV) today announced the signing of a collaborative agreement, to develop a new-fixed dose artemisinin combination therapy drug (ACT), combining chlorproguanil, dapsone and artesunate (CDA) for the treatment of malaria.

23 Apr 2004

Research may offer potent vaccines for viruses such as HIV and West Nile

Researchers at La Jolla Institute for Allergy & Immunology (LIAI) have identified two molecules (TL and CD8aa) that cooperate to trigger immune cells to develop into long-lived memory cells to fight recurring infections. This finding may have important implications for the future development of longer lasting and more potent vaccines for viruses such as HIV and West Nile.

23 Apr 2004

Hepatitis B vaccination for inmates

rrectional settings provide a unique opportunity to offer hepatitis B vaccination to a substantial number of high-risk adults who are willing to be vaccinated and who would not otherwise have access to the preventive medicine, according to a new Brown University study of inmates within the Rhode Island Department of Corrections.

23 Apr 2004